LABIANA HEALTH S.A.EO-10 (8RK) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.55x

LABIANA HEALTH S.A.EO-10 (8RK) has a Cash Flow Reinvestment Rate of 0.55x as of December 2024, reinvesting €3.95 Million (capex €3.05 Million plus investments €-902.84K) from operating cash flow of €7.19 Million. Explore capital reinvestment ratio of LABIANA HEALTH S.A.EO-10 to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.55x
(Capex + Investments) / Operating CF

Total Reinvested

€3.95 Million
Capex + Investments

Operating Cash Flow

€7.19 Million
EUR

Capital Expenditures

€3.05 Million
EUR

LABIANA HEALTH S.A.EO-10 Cash Flow Reinvestment Rate (2021–2024)

Historical reinvestment intensity for LABIANA HEALTH S.A.EO-10 across 3 annual periods. Also explore balance sheet size of LABIANA HEALTH S.A.EO-10 for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for LABIANA HEALTH S.A.EO-10 (2021–2024)

Year-by-year capital reinvestment analysis for LABIANA HEALTH S.A.EO-10. For live market cap and broader valuation context, see 8RK market cap overview.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 0.55x €3.95 Million €7.19 Million €3.05 Million ▼ -67.7%
2022 1.70x €7.96 Million €4.68 Million €5.45 Million ▼ -21.7%
2021 2.17x €8.49 Million €3.91 Million €4.77 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow